Are endogenous LH levels during ovarian stimulation for IVF using GnRH analogues associated with the probability of ongoing pregnancy? A systematic review [1]

Human Reproduction Update

Volumn 12, Issue 3, 2006, Pages 325-326

  Humaidan, Peter ^a  

^a VIBORG HOSPITAL   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

GONADORELIN AGONIST; GONADORELIN ANTAGONIST; GONADORELIN DERIVATIVE; LUTEINIZING HORMONE; RECOMBINANT FOLLITROPIN; RECOMBINANT LUTEINIZING HORMONE;

CLINICAL TRIAL; DOWN REGULATION; FEMALE; FERTILIZATION IN VITRO; HORMONAL REGULATION; HUMAN; IMMUNOREACTIVITY; LETTER; NIDATION; OVARY FOLLICLE; PATIENT IDENTIFICATION; PREGNANCY OUTCOME; PREGNANCY RATE; PRIORITY JOURNAL; PROBABILITY; SUPPLEMENTATION; SYSTEMATIC REVIEW; WORLD HEALTH ORGANIZATION;

FEMALE; FERTILIZATION IN VITRO; GONADOTROPIN-RELEASING HORMONE; HUMANS; LUTEINIZING HORMONE; OVULATION INDUCTION; PREGNANCY; PROBABILITY;

EID: 33645831775     PISSN: 13554786     EISSN: 14602369     Source Type: Journal    
DOI: 10.1093/humupd/dml005     Document Type: Letter

References (8)

1. De Placido G, Alviggi C, Perino A, Strina I, Lisi F, Fasotino A, De Paolo A, Ranieri A, Colacurci N and Mollo A (2005) Recombinant human LH supplementation versus recombinant human FSH (rFSH) step-up protocol during controlled ovarian stimulation in normogonadotrophic women with initial inadequate ovarian response to rFSH. A multicentre, prospective, randomised controlled trial. Hum Reprod 20,390-396.
2. Huhtaniemi I, Jiang M, Nilsson C and Pettersson K (1999) Mutations and polymorphisms in gonadotropin genes. Mol Cell Endocrinol 151,89-94.
3. Humaidan P, Bungum L, Bungum M and Andersen CY (2002) Ovarian response and pregnancy outcome related to mid-follicular LH levels in women undergoing assisted reproduction with GnRH agonist downregulation and recombinant FSH stimulation. Hum Reprod 17,2016-2021.
4. Humaidan P, Bungum M, Bungum L and Andersen CY (2004) Effects of recombinant LH supplementation in women undergoing assisted reproduction with GnRH agonist down-regulation and stimulation with recombinant FSH: an opening study. Reprod Biomed Online 8,635-643.
5. Jiang M, Pakarinen P, Zhang FP, El-Hefnaw T, Koskimies P, Pettersson K and Huhtaniemi I (1999) A common polymorphic allele of the human luteinizing hormone beta-subunit gene: Additional mutations and differential function of the promoter sequence. Hum Mol Genet 8,2037-2046.
6. Kolibianakis EM, Collins J, Tarlatzis B, Papanikolaou E and Devroey P (2006) Are endogenous LH levels during ovarian stimulation for IVF using GnRH analogues associated with the probability of ongoing pregnancy? A systematic review. Hum Reprod Update 12,3-12.
7. Kolibianakis EM, Zikopoulos K, Schiettecatte J, Smitz J, Tournaye H, Camus M, Van steirteghem AC and Devroey P (2004) Profound LH suppression after GnRH antagonist administration is associated with a significantly higher ongoing pregnancy rate in IVF. Hum Reprod 19,2490-2496.
8. Ropelato MG, Garcia-Rudaz MC, Castro-Fernandez C, Ullora-Aguirre A, Escobar ME, Barontini M and Veldhuis JD (1999) A preponderance of basic luteinizing hormone (LH) isoforms accompanies inappropriate hypersecretion of both basal and pulsatile LH in adolescents with polycystic ovarian syndrome. J Clin Endocrinol Metab 84,4629-4636.